14% tested in “in vitro” revealed specific antibodies against coronavirus

At the end of the first week of mass testing for antibodies to the new coronavirus infection of SARS-COV-2 laboratories “in vitro” was defined by the presence of immunoglobulins G 14% tested, indicating the formation of their immune response to COVID-19. In this case only the first four days of analysis for the qualitative determination of antibodies of class G (IgG) against the coronavirus passed more than 40 000 people, the company said.

Data by region were as follows. The maximum number of patients were referred to perform research in medical offices Invitro in Moscow and Moscow region – more than 47%. On the second and third place – the North-Western Federal district and the Volga region, which accounted for 14.6% and 9.5%, respectively. Fourth place in the number of people willing to test the presence of antibodies to SARS-COV-2 occupied Siberia with the rate of 8.6%. The top five most active regions of the Central Federal district is 7.9% of the performed tests.

Immunoglobulins G are beginning to be produced in the body through 21-28 days after contact with the virus, their level increases slowly but for a long time can remain high. Testing for antibodies gives a more reliable indication of the extent of the pandemic.

Leave a Reply

Your email address will not be published. Required fields are marked *


The total number of deaths from coronavirus, has exceeded 700,000

Worldwide, the number of deaths from coronavirus infection was over 700,000. Leaders in deaths from COVID-19 were the United States, Brazil, India and Mexico. Approximately 24 hours from the coronavirus dies 5900 people, is about 247 people every hour, or 1 person in 15 seconds, according to Reuters.

Microgen expands production of preparations for allergen-specific immunotherapy

Scientific-production Association “Microgen” has concluded the agreement with JSC “Biomed” them. I. I. Mechnikov (member of JSC “Pharmstandard”) about acquisition of rights on 31 name of diagnostic and therapeutic allergens. This will allow you to organize in Russia the production of new drugs against allergies on the advanced technology. Following the transaction, the company’s portfolio […]